VIOXX® Litigation Week Two
VIOXX® Trial Week Two: “Risk of Heart Attacks Can Occur at Any Time,” Cardiologist Testifies; Jurors Learn About “Scientific Misconduct” and “Intimidation.” For Immediate Release – Feb. 2, 2007 ATLANTIC CITY, N.J. – A top cardiologist has testified, during the second week of trial, that virtually all relevant medical studies about the drug VIOXX®, including Merck’s […]
VIOXX® Litigation Week Two Read More »